←Back to Expert Scholars
Translational Medicine / 转化医学Cutaneous Squamous Cell Carcinoma
Michael Migden
MD
🏢MD Anderson Cancer Center🌐USA
Professor of Dermatology and Head and Neck Surgery
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Michael Migden led pivotal trials of cemiplimab in advanced cutaneous squamous cell carcinoma including EMPOWER-CSCC 1. His work established immunotherapy as a standard of care for advanced cSCC. He continues to advance adjuvant and neoadjuvant strategies.
Share:
🧪Research Fields 研究领域
cutaneous squamous cell carcinoma
cemiplimab
pembrolizumab
immunotherapy
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Michael Migden 的研究动态
Follow Michael Migden's research updates
留下邮箱，当我们发布与 Michael Migden（MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment